CompaniesHoechst Marion Roussel

Hoechst Marion Roussel

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

4

As Collaborator

4

Total Enrollment

5,858

By Phase

PHASE3: 1PHASE2: 4PHASE1: 2NA: 1

By Status

COMPLETED: 8
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
Today
NCT00007657
Hover over trial bars to see details

Recent Trials

NCT00007657Collaborator
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
PHASE3Completed
3,260 participants
Started: Dec 31, 1998 · Completed: Jun 30, 2006
NCT00002150Lead Sponsor
A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
PHASE2Completed
200 participants
NCT00002151Lead Sponsor
A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
PHASE2Completed
200 participants
NCT00002329Lead Sponsor
A Study of MDL 28,574A in HIV-Infected Patients
PHASE1Completed
NCT00002357Lead Sponsor
The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
PHASE2Completed
144 participants
View all 8 trials →
Funding History (5)
8-K
Jul 18, 1995
Filing
8-K
Jun 30, 1995
Filing
DEFA14C
Jun 28, 1995
Filing
DEFM14C
Jun 27, 1995
Filing
8-K
May 9, 1995
Filing
Related Companies
Rhône-poulenc 1999
merged